Caris Life Sciences, Inc. - Common Stock (NQ:CAI)
27.44
+1.31
(+5.01%)
Streaming Delayed Price
Updated: 12:44 PM EDT, Aug 25, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 2,331,744 |
| Open | 26.19 |
| Bid (Size) | 27.43 (300) |
| Ask (Size) | 27.45 (700) |
| Prev. Close | 26.13 |
| Today's Range | 25.77 - 27.48 |
| 52wk Range | 14.19 - 40.40 |
| Shares Outstanding | 17,357,549 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Caris Life Sciences Q2 Earnings Call Highlights ↗
August 05, 2026
Why ASML’s AI Monopoly Is Still Getting Stronger ↗
July 15, 2026
Venture Philanthropy Blueprint by Alain Leroy Published
June 13, 2026
Frequently Asked Questions
Is Caris Life Sciences, Inc. - Common Stock publicly traded?
Yes, Caris Life Sciences, Inc. - Common Stock is publicly traded.
What exchange does Caris Life Sciences, Inc. - Common Stock trade on?
Caris Life Sciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Caris Life Sciences, Inc. - Common Stock?
The ticker symbol for Caris Life Sciences, Inc. - Common Stock is CAI on the Nasdaq Stock Market
What is the current price of Caris Life Sciences, Inc. - Common Stock?
The current price of Caris Life Sciences, Inc. - Common Stock is 27.44
When was Caris Life Sciences, Inc. - Common Stock last traded?
The last trade of Caris Life Sciences, Inc. - Common Stock was at 08/25/26 12:44 PM ET
What is the market capitalization of Caris Life Sciences, Inc. - Common Stock?
The market capitalization of Caris Life Sciences, Inc. - Common Stock is 476.29M
How many shares of Caris Life Sciences, Inc. - Common Stock are outstanding?
Caris Life Sciences, Inc. - Common Stock has 476M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube